Clinical Trial Update: To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the dose-response of three doses of Euphorbia Prostrata in patients with first- and second-degree hemorrhoids; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhoids

Drugs mentioned

• Euphorbia Prostrata (Euphorbia prostrata)

Snippet

Sponsor: Panacea Biotec Ltd | Conditions: Hemorrhoids | Phase 2 | Status: COMPLETED